Parallel chemical and phylogenetic investigation of a marine cyanobacterium from Panama led to the isolation of two new PKS-NRPS-derived compounds, viridamides A and B. Their structures were determined by NMR and mass spectroscopic methods, and the absolute configurations assigned by Marfey's method and chiral HPLC analysis. In addition to six standard, N-methylated amino and hydroxy acids, these metabolites contained the structurally novel 5-methoxydec-9-ynoic acid moiety and an unusual proline methyl ester terminus. Morphologically, this cyanobacterium was identified as Oscillatoria nigro-viridis, and its 16S rDNA sequence is reported here for the first time. Phylogenetic analysis of these sequence data has identified O. nigro-viridis strain OSC3L to be closely related to two other marine cyanobacterial genera, Trichodesmium and Blennothrix. Viridamide A showed antitrypanosomal activity with an IC50 of 1.1 microM and antileishmanial activity with an IC50 of 1.5 microM.
Parallel chemical and phylogenetic investigation of a marine cyanobacterium from Panama led to the isolation of two new PKS-NRPS-derived compounds, n class="Chemical">viridamides A and B. Their structures were determined by NMR and mass spectroscopic methods, and the absolute configurations assigned by Marfey's method and chiral HPLC analysis. In addition to six standard, N-methylated amino and hydroxy acids, these metabolites contained the structurally novel 5-methoxydec-9-ynoic acid moiety and an unusual proline methyl ester terminus. Morphologically, this cyanobacterium was identified as Oscillatoria nigro-viridis, and its 16S rDNA sequence is reported here for the first time. Phylogenetic analysis of these sequence data has identified O. nigro-viridis strain OSC3L to be closely related to two other marine cyanobacterial genera, Trichodesmium and Blennothrix. Viridamide A showed antitrypanosomal activity with an IC50 of 1.1 microM and antileishmanial activity with an IC50 of 1.5 microM.
Authors: Patrice Trouiller; Piero Olliaro; Els Torreele; James Orbinski; Richard Laing; Nathan Ford Journal: Lancet Date: 2002-06-22 Impact factor: 79.321
Authors: Benjamin R Clark; Niclas Engene; Margaret E Teasdale; David C Rowley; Teatulohi Matainaho; Frederick A Valeriote; William H Gerwick Journal: J Nat Prod Date: 2008-08-13 Impact factor: 4.050
Authors: Daniel J Edwards; Brian L Marquez; Lisa M Nogle; Kerry McPhail; Douglas E Goeger; Mary Ann Roberts; William H Gerwick Journal: Chem Biol Date: 2004-06
Authors: Philippe J Guerin; Piero Olliaro; Shyam Sundar; Marleen Boelaert; Simon L Croft; Philippe Desjeux; Monique K Wasunna; Anthony D M Bryceson Journal: Lancet Infect Dis Date: 2002-08 Impact factor: 25.071
Authors: Niclas Engene; Hyukjae Choi; Eduardo Esquenazi; Tara Byrum; Francisco A Villa; Zhengyu Cao; Thomas F Murray; Pieter C Dorrestein; Lena Gerwick; William H Gerwick Journal: J Nat Prod Date: 2011-07-13 Impact factor: 4.050
Authors: Shangwen Luo; Hahk-Soo Kang; Aleksej Krunic; Wei-Lun Chen; Jilai Yang; John L Woodard; James R Fuchs; Sang Hyun Cho; Scott G Franzblau; Steven M Swanson; Jimmy Orjala Journal: Bioorg Med Chem Date: 2015-05-01 Impact factor: 3.641
Authors: Niclas Engene; Hyukjae Choi; Eduardo Esquenazi; Erin C Rottacker; Mark H Ellisman; Pieter C Dorrestein; William H Gerwick Journal: Environ Microbiol Date: 2011-04-07 Impact factor: 5.491